Pediatric medulloblastoma–update on molecular classification driving targeted therapies
RM DeSouza, BRT Jones, SP Lowis… - Frontiers in oncology, 2014 - frontiersin.org
As advances in the molecular and genetic profiling of pediatric medulloblastoma evolve,
associations with prognosis and treatment are found (prognostic and predictive biomarkers) …
associations with prognosis and treatment are found (prognostic and predictive biomarkers) …
Metabolic Regulation of Endothelial Cells: A New Era for Treating Wet Age-Related Macular Degeneration
X Chen, Y Xu, Y Ju, P Gu - International Journal of Molecular Sciences, 2024 - mdpi.com
Wet age-related macular degeneration (wet AMD) is a primary contributor to visual
impairment and severe vision loss globally, but the prevailing treatments are often …
impairment and severe vision loss globally, but the prevailing treatments are often …
[HTML][HTML] Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways
G Liang, M Liu, Q Wang, Y Shen, H Mei, D Li, W Liu - Oncotarget, 2017 - ncbi.nlm.nih.gov
Malignant melanoma is the deadliest form of all skin cancers. Itraconazole, a commonly
used systemic antifungal drug, has been tested for its anti-tumor effects on basal cell …
used systemic antifungal drug, has been tested for its anti-tumor effects on basal cell …
The cholesterol biosynthesis enzyme oxidosqualene cyclase is a new target to impair tumour angiogenesis and metastasis dissemination
Aberrant cholesterol homeostasis and biosynthesis has been observed in different tumour
types. This paper investigates the role of the post-squalenic enzyme of cholesterol …
types. This paper investigates the role of the post-squalenic enzyme of cholesterol …
Molecular mechanisms of class B GPCR activation: insights from adrenomedullin receptors
Adrenomedullin (AM) is a 52 amino acid peptide that plays a regulatory role in the
vasculature. Receptors for AM comprise the class BG protein-coupled receptor, the …
vasculature. Receptors for AM comprise the class BG protein-coupled receptor, the …
Inhibition of 11β-hydroxysteroid dehydrogenase 2 by the fungicides itraconazole and posaconazole
KR Beck, M Bächler, A Vuorinen, S Wagner… - Biochemical …, 2017 - Elsevier
Impaired 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2)-dependent cortisol
inactivation can lead to electrolyte dysbalance, hypertension and cardiometabolic disease …
inactivation can lead to electrolyte dysbalance, hypertension and cardiometabolic disease …
Successful treatment of oral itraconazole for infantile hemangiomas: a case series
Y Ran, S Chen, Y Dai, D Kang, J Lama… - The Journal of …, 2015 - Wiley Online Library
Infantile hemangiomas can present a therapeutic challenge to clinicians, especially when
associated with severe pain and feeding difficulties. The standard therapeutic management …
associated with severe pain and feeding difficulties. The standard therapeutic management …
[HTML][HTML] Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenib
Sorafenib is a multikinase inhibitor employed for managing hepatocellular carcinoma
(HCC). The emergence of sorafenib resistance presents an obstacle to its therapeutic …
(HCC). The emergence of sorafenib resistance presents an obstacle to its therapeutic …
Out‐of‐the‐Box Nanocapsules Packed with On‐Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy
D Zhao, K Jiang, Y Wang, J Cheng, F Mo… - Advanced …, 2021 - Wiley Online Library
Most anticancer drugs, particularly paclitaxel (PTX), are suffering the challenges of cancer
chemotherapy due to their poor water‐solubility, high toxicity under effective therapeutic …
chemotherapy due to their poor water‐solubility, high toxicity under effective therapeutic …
Co-delivery of repurposing Itraconazole and VEGF siRNA by composite nanoparticulate system for collaborative anti-angiogenesis and anti-tumor efficacy against …
M **, B Zeng, Y Liu, L **, Y Hou, C Liu, W Liu, H Wu… - Pharmaceutics, 2022 - mdpi.com
Combinations of two different therapeutic modalities of VEGF inhibitors against
angiogenesis can cooperatively impede breast cancer tumor growth and enhance …
angiogenesis can cooperatively impede breast cancer tumor growth and enhance …